Colorectal Cancer Trial, Recruiting NCT03587480 Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT03587480
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with rectal cancer (a type of gland-based cancer located in the lower part of the bowel, below a certain internal boundary called the peritoneal reflection), confirmed through a tissue test
  • People whose cancer is classified as Stage III
  • People whose tumor is considered removable by surgery with the aim of clearing all cancer
  • People who have not previously had chemotherapy or radiation therapy to the pelvic area for any cancer
  • People whose cancer has been assessed by a team of specialists (including surgeons, radiologists, and oncologists) using MRI and ultrasound, and confirmed to be at a specific stage (T1–3, N1–2, M0, meaning the cancer has not spread to distant parts of the body)
  • People who have given written consent to participate

Who may not be able to join:

  • People with a past history of another type of cancer
  • People with multiple colorectal cancers at the same time, or a condition called Familial Adenomatous Polyposis (FAP), which is an inherited bowel condition
  • People who also have inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis
  • People whose cancer has come back after previous treatment, or has grown into nearby organs
  • People whose cancer is causing a blockage, a tear in the bowel, or serious bleeding that requires emergency surgery
  • People whose tumor has grown into specific muscles or structures around the bowel (the external sphincter, levator ani muscle, or adjacent organs)
  • People who have taken part in another clinical trial within the past 4 weeks
  • People who are rated as being in poor general health according to standard medical scoring tools used by anaesthetists and oncologists (confirm with trial site for exact scoring thresholds)
  • People who are pregnant or breastfeeding
  • People who have a serious infection before surgery
  • People with a psychological disorder
  • People with severe organ dysfunction or other medical reasons that make participation unsafe
  • People who have had a heart attack within the past six months
  • People with severe lung conditions such as emphysema or pulmonary fibrosis
  • People excluded based on the treating doctor's clinical judgment
  • People where, during surgery, the tumor is found to have grown into other organs, or the tumor location does not match the original assessment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yanxin Luo, Sixth Affiliated Hospital, Sun Yat-sen University

Phone: 020-38250745

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Registry
ClinicalTrials.gov
Start date
17 December 2018
Est. completion
24 May 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

3-year disease-free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov